Cosciens Biopharma Inc.
13F holders, Q1 2025 (March 31)15holders
1new positions
2sold out
$2.84avg. 13F price*
At the end of Q1 2025, 15 institutions reported holding Cosciens Biopharma Inc. in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Susquehanna International Group, LLP ($35K), Royal Bank of Canada ($11K) and TD Waterhouse Canada Inc. ($11K).
- Company
- Cosciens Biopharma Inc.
- CUSIP
- 22112H101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $35K |
| Exits | 2 | $3K |
All 13F filers, Q4 2024 → Q1 2025: 13,660 shares bought and 7,618 shares sold, net +6,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Susquehanna International Group, LLP | 0.00% | New | 11,907 | $35K |
| Royal Bank of Canada | 0.00% | Reduce -1.8% | 3,867 | $11K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 3,717 | $11K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -27.4% | 2,812 | $7K |
| UBS Group AG | 0.00% | Add +240.7% | 2,337 | $7K |
| National Bank of Canada | 0.00% | Reduce -81.0% | 1,122 | $3K |
| Morgan Stanley | 0.00% | Add +25.5% | 502 | $1K |
| MAI Capital Management | 0.00% | Reduce -65.2% | 401 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 165 | $465 |
| BNP Paribas Financial Markets | 0.00% | No change | 100 | $291 |
| Osaic Holdings, Inc. | 0.00% | No change | 50 | $145 |
| Graybill Wealth Management, LTD. | 0.00% | — | 50 | $141 |
| Group One Trading LLC | 0.00% | No change | 37 | $108 |
| Truvestments Capital LLC | 0.00% | No change | 22 | $62 |
| Groupe la Francaise | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is COSCIENS BIOPHARMA INC's weight in each manager's 13F, not the share of Cosciens Biopharma Inc. the manager owns.